Inhibikase Therapeutics, Inc. · NASDAQ:IKT
Armistice Capital, LLC's stake in Inhibikase Therapeutics, Inc. fell to 4.99% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Armistice Capital, LLC's stake in Inhibikase Therapeutics, Inc. fell to 4.99%, 3,529,006 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 3,529,006
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 4.99% | 3,529,006 |
| Steven Boyd | 4.99% | 3,529,006 |
Source
Related
- Inhibikase Therapeutics, Inc.
- Armistice Capital, LLC
- Inhibikase Therapeutics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Sands Capital Life Sciences Pulse Fund II, L.P. · Aug 13, 2026
- Form 4 · Berman Dennis N · Jul 31, 2026
- Form 4 · RA Capital Healthcare Fund LP · Jul 31, 2026